David Glenn has filed 7 insider transactions across 1 company since February 2024.
Most recent transaction: a option exercise of 30000 shares of PHIBRO ANIMAL HEALTH CORP ($PAHC) on February 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | M | Restricted Stock Units | 30000 | $0.00 | 240,000.0000 | 40,956,000 | 11.11% | 0.07% |
| Feb. 9, 2026 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | M | Class A Common Stock | 30000 | $0.00 | 64,845.0000 | 40,956,000 | 86.10% | 0.07% |
| Feb. 11, 2026 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | J | Class A Common Stock | 12528 | $51.63 | 52,317.0000 | 40,956,000 | 19.32% | 0.03% |
| Aug. 15, 2025 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | A | Class A Common Stock | 4845 | $0.00 | 34,845.0000 | 40,678,000 | 16.15% | 0.01% |
| Feb. 9, 2025 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | M | Class A Common Stock | 30000 | $0.00 | 30,000.0000 | 40,715,000 | 9999.99% | 0.07% |
| Feb. 9, 2025 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | M | Restricted Stock Units | 30000 | $0.00 | 270,000.0000 | 40,715,000 | 10.00% | 0.07% |
| Feb. 9, 2024 | PHIBRO ANIMAL HEALTH CORP | $PAHC | David Glenn | Chief Financial Officer | A | Restricted Stock Units | 300000 | $0.00 | 300,000.0000 | 40,504,000 | 9999.99% | 0.74% |